Pfizer asks US officials to OK promising COVID-19 pill |

Pfizer asks US officials to OK promising COVID-19 pill

Pfizer COVID-19 pill Pfizer COVID-19 pill |  Photo: Pxfuel / Ysiulec / Wikimedia / CC BY-SA 3.0

Associated Press
Created: November 16, 2021 01:46 PM

WASHINGTON (AP) — Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks. The company’s antiviral is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19.

If authorized by the Food and Drug Administration it could be a major step toward managing the pandemic, allowing patients to treat themselves at home.

FDA regulators will scrutinize company data on the safety and effectiveness of the drug, which will be sold as Paxlovid, before making a decision.


Associated Press

Copyright 2021 The Associated Press. All rights reserved.

Finalizing Superior's 20 year Comprehensive Plan

Tenants have to scramble after flooding due to a broken sprinkler system has displaced them

Will boosters be effective against the new Omicron variant?

Kwik Trip to require pre-pay or pay-at-the-pump

Home in St. Louis County a total loss after fire

Meadows book: Trump tested positive before visiting Duluth